Thomas Digby, Attorney

Global IP Lead


Novateur Advisor Since



Intellectual Property


Patents, COVID-19, Devices, Drug Delivery, Drug & Device Combination, Licensing and M&A, Therapeutics

“Our practical IP advice helps you secure your innovations and attract investors and corporate partners.”

Thomas Digby, Attorney
Global IP Lead

Thomas Digby is a US and Canadian intellectual property (IP) and transaction attorney. He works in the fields of small molecule NCEs, biologics, generics and biosimilars, research-tools and therapeutic targets, biofuels, and biomass-derived chemicals. With over 25 years in practice, Thomas has advised a wide range of clients, from seed-stage, VC-funded startups through to global pharma with Novartis. While at Novartis, Thomas led a specialized IP Asset Management team focused on enforcement of IP rights, with the goal of revenue generation. Enforcement proceeds during 2012-2015 were over $650 million.

Thomas has specific expertise in license and M&A due diligence, negotiation, and dispute resolution. He also has deep experience in complex global IP issues relating to tax, transfer-pricing, supply-chain management, and compliance with international trade sanctions. Thomas holds a Doctor of Law degree from Dalhousie University.

Novateur Newsletter

Subscribe to our newsletter for access to latest updates.

Resource Databases

Access Novateur news as well as FDA and Expert Databases.

Relevant Events

Check out conferences and events we are attending!